Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design

被引:7
作者
Mullins, James I. [2 ,3 ]
Rolland, Morgane [2 ,3 ]
Allen, Todd M. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
evolution; HIV; T lymphocyte; viral proteins;
D O I
10.1097/COH.0b013e3282f233d9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The ability of human immunodeficiency virus to mutate rapidly to evade host immune pressures is a key hurdle limiting the control of human immunodeficiency virus-1 by cellular immune responses. Viral escape from CD8(+) T-cell recognition continues to be studied extensively, and emerging data provide greater appreciation of the affect of these mutations on the virus. These data may help identify key immune responses capable of suppressing viral replication. This goal remains critical, as current vaccines are unlikely to produce protective T-cell immunity. Recent findings Recent studies provide greater understanding of the propensity for transmitted mutations to revert, and of the ability of CD8(+) T-cell escape mutations to impact viral replication capacity and protein structure. These observations reveal important constraints on virus evolution and sequence diversity. Data are also accumulating for the ability of the immune system to mount de-novo CD8(+) T-cell responses against escape variants, revealing an underappreciated complexity of the process of viral escape. Summary Understanding the limits of sequence variation and the impact of immune escape mutations on viral fitness, particularly during acute infection, will be critical to guide the design of contemporary vaccines or therapeutics attempting to force human immunodeficiency viruses to become less fit.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
[41]   Evaluation of Human Immunodeficiency Virus-1/2 Antigen/Antibody Immunochromatographic Assay [J].
Deguchi, Matsuo ;
Yoshioka, Nori ;
Kagita, Masanori ;
Kita, Mifumi ;
Asari, Seishi ;
Honda, Tomoe ;
Kobayashi, Eiji .
CLINICAL LABORATORY, 2012, 58 (11-12) :1193-1201
[42]   Safety of cryopreservation straws for human gametes or embryos:: a preliminary study with human immunodeficiency virus-1 [J].
Benifla, JL ;
Letur-Konïrsch, H ;
Collin, G ;
Devaux, A ;
Kuttenn, F ;
Madelenat, P ;
Brun-Vezinet, F ;
Feldmann, G .
HUMAN REPRODUCTION, 2000, 15 (10) :2186-2189
[43]   Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection [J].
Nachman, S ;
Kim, S ;
King, J ;
Abrams, EJ ;
Margolis, D ;
Petru, A ;
Shearer, W ;
Smith, E ;
Moye, J ;
Blanchard, S ;
Hawkins, E ;
Bouquin, P ;
Vink, P ;
Benson, M ;
Estep, S ;
Malinoski, F .
PEDIATRICS, 2003, 112 (01) :66-73
[44]   RENAL INVOLVEMENT DURING INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
PHAN, F ;
LEROY, B ;
PRESSAC, M ;
COURPOTIN, C ;
PALOMERA, S ;
BENSMAN, A .
ANNALES DE PEDIATRIE, 1994, 41 (02) :115-123
[45]   Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets [J].
Mbita, Zukile ;
Hull, Rodney ;
Dlamini, Zodwa .
VIRUSES-BASEL, 2014, 6 (08) :3181-3227
[46]   Serological survey for the infection of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and human T-lymphotropic virus-1 among isolated ethnic groups in Nepal [J].
Singh, NB ;
Takao, S ;
Ishida, T .
ANTHROPOLOGICAL SCIENCE, 2002, 110 (02) :179-183
[47]   Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs [J].
Staudinger, R ;
Abraham, NG ;
Levere, RD ;
Kappas, A .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1996, 108 (01) :47-54
[48]   VIRICIDAL EFFECT OF POLYMORPHONUCLEAR LEUKOCYTES ON HUMAN IMMUNODEFICIENCY VIRUS-1 - ROLE OF THE MYELOPEROXIDASE SYSTEM [J].
KLEBANOFF, SJ ;
COOMBS, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :2014-2017
[49]   Preliminary experience offering oocyte donation to human immunodeficiency virus-1 serodiscordant couples [J].
Joseph E. Peña ;
Melvin H. Thornton ;
Mark V. Sauer .
Archives of Gynecology and Obstetrics, 2003, 268 (3) :202-205
[50]   A RhoA-Derived Peptide Inhibits Human Immunodeficiency Virus-1 Entry In Vitro [J].
Maselko, Maciej ;
Ward, Casey ;
Pastey, Manoj .
CURRENT HIV RESEARCH, 2011, 9 (01) :1-5